Back to search

Article

Impact of Botulinum Toxin Versus CGRP Monoclonal Antibodies on Return Visits and Acute Medication Use in Chronic Migraine: First Real-World, Multicenter, Head-to-Head Analysis Using TriNetX

2026-01-27

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Botulinum toxin type A and calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) are widely used preventive treatments for chronic migraine. However, real-world comparative evidence regarding their effects on health-care utilization and acute medication use remains lacking. <bold>Objectives:</bold> To directly compare the real-world effectiven...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ae319266-2535-56d1-ba6d-d2df6f10bc7a
DOI
10.21203/rs.3.rs-8506523/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of Botulinum Toxin Versus CGRP Monoclonal Antibodies on Return Visits and Acute Medication Use in Chronic Migraine: First Real-World, Multicenter, Head-to-Head Analysis Using TriNetXDOI 10.21203/rs.3.rs-8506523/v1
Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic ReviewSemantic proximity
Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity
Cgrp Monoclonal Antibodies: Key Lessons from Real World EvidenceSemantic proximity
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022.Semantic proximity
Different Dosage Regimens of Eptinezumab for the Treatment of Migraine: A Meta-Analysis from Randomized Controlled TrialsSemantic proximity
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysisSemantic proximity
Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKSemantic proximity
Comparative Efficacy and Safety of Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Oral Gepants for Episodic Migraine Prevention: A Bayesian Network Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Real-world Treatment and Associated Healthcare Resource Use Among Migraine Patients in GermanySemantic proximity
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity
Select a neighboring publication to make it the new centre.